Blockade of phosphotyrosine pathways suggesting SH2 superbinder as a novel therapy for pulmonary fibrosis

Meng Wang(Huazhong University of Science and Technology), Hong Ye(Capital Medical University)
Theranostics
January 1, 2022
Cited by 5


Related Papers